Documents
Application Sponsors
ANDA 075233 | MYLAN TECHNOLOGIES | |
Marketing Status
Application Products
001 | FILM, EXTENDED RELEASE; TRANSDERMAL | 0.05MG/24HR | 0 | ESTRADIOL | ESTRADIOL |
FDA Submissions
| ORIG | 1 | AP | 2000-02-24 | |
LABELING; Labeling | SUPPL | 2 | AP | 2001-10-25 | |
MANUF (CMC); Manufacturing (CMC) | SUPPL | 3 | AP | 2002-12-23 | |
MANUF (CMC); Manufacturing (CMC) | SUPPL | 4 | AP | 2002-12-23 | |
LABELING; Labeling | SUPPL | 7 | AP | 2005-01-06 | |
LABELING; Labeling | SUPPL | 9 | AP | 2005-01-21 | |
LABELING; Labeling | SUPPL | 10 | AP | 2005-03-04 | |
LABELING; Labeling | SUPPL | 11 | AP | 2005-10-06 | |
LABELING; Labeling | SUPPL | 12 | AP | 2006-07-24 | |
Submissions Property Types
ORIG | 1 | Null | 29 |
SUPPL | 3 | Null | 0 |
SUPPL | 4 | Null | 0 |
TE Codes
CDER Filings
MYLAN TECHNOLOGIES
cder:Array
(
[0] => Array
(
[ApplNo] => 75233
[companyName] => MYLAN TECHNOLOGIES
[docInserts] => ["",""]
[products] => [{"drugName":"ESTRADIOL","activeIngredients":"ESTRADIOL","strength":"0.05MG\/24HR","dosageForm":"FILM, EXTENDED RELEASE; TRANSDERMAL","marketingStatus":"Prescription","te":"","rld":"No","rs":"No"}]
[labels] =>
[originalApprovals] => [{"actionDate":"ESTRADIOL","submission":"ESTRADIOL","actionType":"0.05MG\/24HR","submissionClassification":"FILM, EXTENDED RELEASE; TRANSDERMAL","reviewPriority":"Prescription","inserts":"[]","notes":">No"}]
[supplements] =>
[actionDate] => 1969-12-31
)
)